文献速递脊柱关节炎其他结缔组织病

银屑病关节炎附着点组织对IL-17A抑制的应答特征:EBIO附着点活检研究

Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study.
PubMed 文献 · Ann Rheum Dis · 2025-10-16

这项前瞻性干预性4期试验纳入10例伴外上髁附着点炎的PsA患者,在IL-17A抑制治疗前后行附着点活检,采用成像质谱流式与空间转录组分析。治疗24周后9/10患者临床应答,附着点相关免疫细胞群显著减少,CD200+DKK3+成纤维细胞与2型固有淋巴样细胞扩增形成抗炎微环境,成骨细胞分化标志物下降。

要点

  • IL-17A抑制24周后9/10例PsA患者达临床应答(DAPSA、SPARCC、能量多普勒超声评估)。
  • 治疗后附着点IL-17产生CD4、CD8、CD4neg/CD8neg T细胞、粒细胞及3型固有淋巴样细胞显著减少。
  • CD200+DKK3+成纤维细胞与2型固有淋巴样细胞扩增形成抗炎微环境,成骨细胞分化标志物下降。

核心结论

  • IL-17A在附着点炎中起关键作用,IL-17A抑制可深度调控PsA附着点组织微环境。

研究设计与样本

  • 前瞻性、干预性4期试验,纳入10例外上髁附着点炎的PsA患者,治疗前后行附着点活检,用成像质谱流式与空间转录组分析。

主要发现

  • IL-17A抑制24周后,按DAPSA、SPARCC评分及能量多普勒超声评估,10例中9例临床应答。
  • 成像质谱流式显示附着点炎相关免疫细胞群显著减少,尤其IL-17产生CD4、CD8、CD4neg/CD8neg T细胞、粒细胞及3型固有淋巴样细胞。
  • 空间转录组显示治疗后CD200+DKK3+成纤维细胞与2型固有淋巴样细胞扩增并形成抗炎微环境。
  • IL-17A抑制导致成骨细胞分化标志物下降,提示潜在抑制病理性骨形成的机制。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Enthesitis, a hallmark of psoriatic arthritis (PsA), reflects the interplay between mechanical stress and immune dysregulation at tendon-bone interfaces. This study investigates the cellular and molecular responses in entheseal tissues following interleukin (IL)-17A inhibition in patients with active PsA. METHODS: In this prospective, interventional phase 4 trial, we enrolled 10 patients with enthesitis of the lateral epicondyle, performed entheseal biopsies, and analysed tissues by imaging mass cytometry (IMC) and spatial transcriptomics before and after treatment. RESULTS: Following 24 weeks of IL-17A inhibition, 9/10 patients of the cohort clinically responded to treatment as assessed by Disease Activity in Psoriatic Arthritis (DAPSA), Spondyloarthritis research consortium of canada (SPARCC) score, and power Doppler sonography. IMC analysis showed significant reductions of enthesitis-related immune cell populations, in particular IL-17-producing CD4, CD8, CD4neg/CD8neg T cells, granulocytes, and innate lymphoid cells type 3. Spatial transcriptomics revealed that CD200+DKK3+ fibroblasts and innate lymphoid cells type 2 expanded and formed an anti-inflammatory niche upon treatment. Notably, IL-17A inhibition led to decreased osteoblast differentiation markers, suggesting a potential mechanism to inhibit pathological bone formation. CONCLUSIONS: These findings underline the pivotal role of IL-17A in enthesitis, showing that IL-17A inhibition profoundly modulates the tissue microenvironment of entheses in PsA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Raimondo MG, Mohammadian H, Rauber S, et al. Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. Ann Rheum Dis. 2025. PMID: 41107119. doi:10.1016/j.ard.2025.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。